Medtronic plc
Medtronic plc is a global healthcare technology company headquartered in Dublin, Ireland. Founded in 1949, the company's mission is to alleviate pain, restore health, and extend life. Medtronic's business strategy focuses on leveraging its pipeline to accelerate revenue growth, serving more patients by accelerating innovation-driven growth, creating and disrupting markets with technology, and empowering its operating units to be more nimble and competitive. The company operates through four reportable segments: Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio, and Diabetes Operating Unit. Medtronic's Cardiovascular Portfolio includes products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, such as implantable pacemakers, implantable cardioverter defibrillators, implantable cardiac resynchronization therapy devices, cardiac ablation products, and insertable cardiac monitoring systems. The Medical Surgical Portfolio consists of products for surgical technologies, respiratory interventions, gastrointestinal and renal therapies, and patient monitoring. The Neuroscience Portfolio includes products for neurosurgery, specialty therapies, and neuromodulation. The Diabetes Operating Unit develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes. Medtronic's website is www.medtronic.com, and its ticker symbol is MDT on the New York Stock Exchange.